Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acadia Healthcare (DE:7RA)
FRANKFURT:7RA
Acadia Healthcare (7RA) Stock Price & Analysis
0 Followers
7RA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€61.00 - €80.50
Previous Close€65.5
Volume0.00
Average Volume (3M)20.00
Market Cap
€6.10B
Enterprise Value€7.51B
Total Cash (Recent Filing)$100.07M
Total Debt (Recent Filing)$1.50B
Price to Earnings (P/E)N/A
Beta0.15
Next Earnings
May 01, 2024EPS Estimate
€0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding92,289,068
10 Day Avg. Volume0
30 Day Avg. Volume20
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)13.43
Price to Sales (P/S)8.14
Price to Cash Flow (P/CF)13.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.57
Enterprise Value/Gross Profit2.57
Enterprise Value/Ebitda43.58
Forecast
1Y Price Target
€88.58Price Target Upside35.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Acadia Healthcare News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCompany's strong fourth quarter results and positive guidance signal robust financial health and promising future performance.
Strategic GrowthExpansion activities and new treatment centers are set to enhance the company's service capabilities and market presence.
ValuationACHC shares are attractively valued with potential for growth, underscoring a positive investment opportunity.
Bears Say
Financial IncentivesDecreasing levels of reimbursement and profitability for pharmacies may result in less willingness to stock the company’s products, negatively impacting sales.
Industry PerceptionStigma from medical practitioners could lead to reduced adoption of the company's products, as prescribers and pharmacists are reluctant to include them in their practices and pharmacies.
Regulatory ChallengesHeightened DEA oversight and regulatory uncertainties, especially contradictions with state laws, could pose significant operational challenges for the company.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.75% Other Institutional Investors
99.25% Public Companies and
Individual Investors
7RA FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was €61.00 and its highest was €80.50 in the past 12 months.
What is Acadia Healthcare’s market cap?
Currently, no data Available
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is May 01, 2024 which is in 6 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Feb 27, 2024. The company reported €0.797 earnings per share for the quarter, beating the consensus estimate of €0.743 by €0.053.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is €0.75.
How many shares outstanding does Acadia Healthcare have?
Currently, no data Available
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of €0.797 in its last earnings report, beating expectations of €0.743. Following the earnings report the stock price went up 2.548%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Among the largest hedge funds holding Acadia Healthcare’s share is Viking Global Investors LP. It holds Acadia Healthcare’s shares valued at 218M.
---
Acadia Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€88.58 (35.24% Upside)
€88.58 (35.24% Upside)
Blogger Sentiment
Bullish
DE:7RA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $402.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.02%
12-Months-Change
Fundamentals
Return on Equity
-0.77%
Trailing 12-Months
Asset Growth
7.44%
Trailing 12-Months
Company Description
Acadia Healthcare
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.
---
7RA Earnings Call
Q4 2024
0:00 / 0:00
---
7RA Stock 12 Months Forecast
Average Price Target
€88.58
▲(35.24% Upside)
Technical Analysis
Best Analysts Covering 7RA
1 Year
1 Year Success Rate
11/35 ratings generated profit
1 Year Average Return
+1.31%
reiterated a buy rating 24 days ago
Copying Brian Tanquilut's trades and holding each position for 1 Year would result in 31.43% of your transactions generating a profit, with an average return of +1.31% per trade.
---